In summary, the present study demonstrated that FASN, which is increased in the cancer tissues of CRC patients, promotes cancer cell proliferation, metastasis, and PC metabolism via the SP1/PLA2G4B axis, subsequently suppressing the antitumor response of NK cells in a PC-dependent manner (Graphical Abstract). The gene discussed is FASN; the disease is cancer.